Literature DB >> 3104698

Autoanticoagulation does not preclude pulmonary emboli.

B Phillips, J Woodring.   

Abstract

Mesh：

Year:  1987        PMID： 3104698     DOI： 10.1007/bf02714419

Source DB:  PubMed          Journal:  Lung        ISSN： 0341-2040            Impact factor:   2.584


× No keyword cloud information.
  16 in total

Review 1.  Antithrombotic therapy for venous thromboembolic disease.

Authors:  T M Hyers; R D Hull; J G Weg
Journal:  Chest       Date:  1986-02       Impact factor: 9.410

2.  Lupus anticoagulant, thrombosis, and fetal loss.

Authors:  D I Feinstein
Journal:  N Engl J Med       Date:  1985-11-21       Impact factor: 91.245

3.  Pulmonary embolism.

Authors:  K M Moser
Journal:  Am Rev Respir Dis       Date:  1977-05

4.  Prevention of pulmonary emboli in a respiratory intensive care unit: efficacy of low-dose heparin.

Authors:  S K Pingleton; R C Bone; W W Pingleton; W E Ruth
Journal:  Chest       Date:  1981-06       Impact factor: 9.410

5.  Pulmonary angiography, ventilation lung scanning, and venography for clinically suspected pulmonary embolism with abnormal perfusion lung scan.

Authors:  R D Hull; J Hirsh; C J Carter; R M Jay; P E Dodd; P A Ockelford; G Coates; G J Gill; A G Turpie; D J Doyle; H R Buller; G E Raskob
Journal:  Ann Intern Med       Date:  1983-06       Impact factor: 25.391

6.  [Hepatic lesions and coagulation disorders in pulmonary embolism: a clinico-pathological case].

Authors:  C Focan; J Bury; R Marcelle
Journal:  Acta Cardiol       Date:  1976       Impact factor: 1.718

7.  Thrombosis in systemic lupus erythematosus: striking association with the presence of circulating lupus anticoagulant.

Authors:  M L Boey; C B Colaco; A E Gharavi; K B Elkon; S Loizou; G R Hughes
Journal:  Br Med J (Clin Res Ed)       Date:  1983-10-08

8.  Thromboembolism in patients with the 'lupus'-type circulating anticoagulant.

Authors:  M Elias; A Eldor
Journal:  Arch Intern Med       Date:  1984-03

9.  Thromboembolism in patients with hereditary deficiency of coagulation factors.

Authors:  D L Solanki; M Corn
Journal:  South Med J       Date:  1980-07       Impact factor: 0.954

10.  Adjusted subcutaneous heparin versus warfarin sodium in the long-term treatment of venous thrombosis.

Authors:  R Hull; T Delmore; C Carter; J Hirsh; E Genton; M Gent; G Turpie; D McLaughlin
Journal:  N Engl J Med       Date:  1982-01-28       Impact factor: 91.245
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.